The post DOGE Price Prediction for August 31 appeared on BitcoinEthereumNews.com. Most coins from the top 10 list are rising today, according to CoinStats. Top coins by CoinStats DOGE/USD The rate of DOGE has gone up by 0.48% since yesterday. Over the last week, the price has fallen by 5.58%. Image by TradingView On the hourly chart, the price of the meme coin is on the way to the local support of $0.2159. You Might Also Like If bulls cannot seize the initiative by the end of the day, traders may see a level breakout followed by a further correction to the $0.2150 mark. Image by TradingView On the bigger time frame, the situation is similar. In this regard, traders should pay attention to the nearest level of $0.2074. If the daily candle closes below that mark, there is a chance of a test of the $0.20 range soon. Image by TradingView From the midterm point of view, the situation is less clear. The price of DOGE is in the middle of the channel between the support of $0.1884 and the resistance of $0.2867. As neither side is dominating, any sharp moves are unlikely to happen soon. DOGE is trading at $0.2173 at press time. Source: https://u.today/doge-price-prediction-for-august-31The post DOGE Price Prediction for August 31 appeared on BitcoinEthereumNews.com. Most coins from the top 10 list are rising today, according to CoinStats. Top coins by CoinStats DOGE/USD The rate of DOGE has gone up by 0.48% since yesterday. Over the last week, the price has fallen by 5.58%. Image by TradingView On the hourly chart, the price of the meme coin is on the way to the local support of $0.2159. You Might Also Like If bulls cannot seize the initiative by the end of the day, traders may see a level breakout followed by a further correction to the $0.2150 mark. Image by TradingView On the bigger time frame, the situation is similar. In this regard, traders should pay attention to the nearest level of $0.2074. If the daily candle closes below that mark, there is a chance of a test of the $0.20 range soon. Image by TradingView From the midterm point of view, the situation is less clear. The price of DOGE is in the middle of the channel between the support of $0.1884 and the resistance of $0.2867. As neither side is dominating, any sharp moves are unlikely to happen soon. DOGE is trading at $0.2173 at press time. Source: https://u.today/doge-price-prediction-for-august-31

DOGE Price Prediction for August 31

Most coins from the top 10 list are rising today, according to CoinStats.

Top coins by CoinStats

DOGE/USD

The rate of DOGE has gone up by 0.48% since yesterday. Over the last week, the price has fallen by 5.58%.

Image by TradingView

On the hourly chart, the price of the meme coin is on the way to the local support of $0.2159.

You Might Also Like

If bulls cannot seize the initiative by the end of the day, traders may see a level breakout followed by a further correction to the $0.2150 mark.

Image by TradingView

On the bigger time frame, the situation is similar. In this regard, traders should pay attention to the nearest level of $0.2074. If the daily candle closes below that mark, there is a chance of a test of the $0.20 range soon.

Image by TradingView

From the midterm point of view, the situation is less clear. The price of DOGE is in the middle of the channel between the support of $0.1884 and the resistance of $0.2867. As neither side is dominating, any sharp moves are unlikely to happen soon.

DOGE is trading at $0.2173 at press time.

Source: https://u.today/doge-price-prediction-for-august-31

Market Opportunity
TOP Network Logo
TOP Network Price(TOP)
$0.000096
$0.000096$0.000096
0.00%
USD
TOP Network (TOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26